Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs LifeStance Health Group Inc. Common Stock (LFST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs LifeStance Health Group Inc. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while LifeStance Health Group Inc. Common Stock trades at $12.7 (market cap $4.69B). The key difference: Indivior Pharmaceuticals Inc. Common Stock and LifeStance Health Group Inc. Common Stock are close in size by market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and LifeStance Health Group Inc. Common Stock for 6 Days on average.
| INDV | LFST | |
|---|---|---|
Market Cap | $4.18B | $4.69B |
Volume | 1,819,746 | 1,858,220 |
Sector | Health | Health |
52-Week High | $41.83 | $13.38 |
52-Week Low | $24.09 | $4.81 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $4.47B | $4.92B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LifeStance Health Group (LFST) trades at $12.32, down 1.28% today, with strong technical momentum showing a bullish moving average signal. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $0.06 exceeding the $0.03 forecast. Revenue growth accelerated from $1.42B in 2025 to $1.6B in 2026, while net income improved significantly from $9.66M to $51M.
Wall Street maintains strong bullish sentiment with 82% buy ratings and a $14.14 consensus price target representing 15% upside. However, elevated valuation multiples (P/E 94.8) and overbought technical conditions near 52-week highs warrant caution. The mental healthcare provider benefits from industry tailwinds but faces execution risks amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About LifeStance Health Group Inc. Common Stock
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →
